Resilience, trust, and civic engagement in the post-CCSVI era

Abstract Background Scientific and financial investments in chronic cerebrospinal venous insufficiency (CCSVI) research have been made to address both the hope for and scepticism over this interventional strategy for MS. Despite limited evidence in support of the CCSVI hypothesis, the funding of cli...

Full description

Bibliographic Details
Main Authors: Shelly Benjaminy, Andrew Schepmyer, Judy Illes, Anthony Traboulsee
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Health Services Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12913-018-3130-x
id doaj-476cfde0d815463fb57a67a1387c7c93
record_format Article
spelling doaj-476cfde0d815463fb57a67a1387c7c932020-11-24T22:01:13ZengBMCBMC Health Services Research1472-69632018-05-011811610.1186/s12913-018-3130-xResilience, trust, and civic engagement in the post-CCSVI eraShelly Benjaminy0Andrew Schepmyer1Judy Illes2Anthony Traboulsee3Neuroethics Canada, University of British ColumbiaDivision of Neurology, Department of Medicine, University of British ColumbiaNeuroethics Canada, University of British ColumbiaDivision of Neurology, Department of Medicine, University of British ColumbiaAbstract Background Scientific and financial investments in chronic cerebrospinal venous insufficiency (CCSVI) research have been made to address both the hope for and scepticism over this interventional strategy for MS. Despite limited evidence in support of the CCSVI hypothesis, the funding of clinical research was responsive to a demand by the public rarely seen in the history of medicine. We characterize patient perspectives about the CCSVI research trajectory, with particular attention to its impact on other non-pharmaceutical areas of MS research with a focus on stem cell interventions. Methods Semi-structured interviews with 20 MS patients across Canada who did not have CCSVI interventions. Interviews were analysed for recurring themes and individual variations using the constant comparative approach. Results Participants had a critical view of the divestment of funds from longstanding research to support CCSVI trials. They retain a sense of optimism, however, about emerging evidence for stem cell interventions for MS, and highlight the need for greater caution and conscientious communication of advances in medicine and science. Conclusions The unrealized hopes for CCSVI challenged but did not undermine the resilience of patient communities. The narrative that unfolded highlights the importance of drawing a socially-minded space for public participation in science.http://link.springer.com/article/10.1186/s12913-018-3130-xHealth services researchPublic engagementMultiple sclerosisChronic cerebrospinal venous insufficiencyEthics
collection DOAJ
language English
format Article
sources DOAJ
author Shelly Benjaminy
Andrew Schepmyer
Judy Illes
Anthony Traboulsee
spellingShingle Shelly Benjaminy
Andrew Schepmyer
Judy Illes
Anthony Traboulsee
Resilience, trust, and civic engagement in the post-CCSVI era
BMC Health Services Research
Health services research
Public engagement
Multiple sclerosis
Chronic cerebrospinal venous insufficiency
Ethics
author_facet Shelly Benjaminy
Andrew Schepmyer
Judy Illes
Anthony Traboulsee
author_sort Shelly Benjaminy
title Resilience, trust, and civic engagement in the post-CCSVI era
title_short Resilience, trust, and civic engagement in the post-CCSVI era
title_full Resilience, trust, and civic engagement in the post-CCSVI era
title_fullStr Resilience, trust, and civic engagement in the post-CCSVI era
title_full_unstemmed Resilience, trust, and civic engagement in the post-CCSVI era
title_sort resilience, trust, and civic engagement in the post-ccsvi era
publisher BMC
series BMC Health Services Research
issn 1472-6963
publishDate 2018-05-01
description Abstract Background Scientific and financial investments in chronic cerebrospinal venous insufficiency (CCSVI) research have been made to address both the hope for and scepticism over this interventional strategy for MS. Despite limited evidence in support of the CCSVI hypothesis, the funding of clinical research was responsive to a demand by the public rarely seen in the history of medicine. We characterize patient perspectives about the CCSVI research trajectory, with particular attention to its impact on other non-pharmaceutical areas of MS research with a focus on stem cell interventions. Methods Semi-structured interviews with 20 MS patients across Canada who did not have CCSVI interventions. Interviews were analysed for recurring themes and individual variations using the constant comparative approach. Results Participants had a critical view of the divestment of funds from longstanding research to support CCSVI trials. They retain a sense of optimism, however, about emerging evidence for stem cell interventions for MS, and highlight the need for greater caution and conscientious communication of advances in medicine and science. Conclusions The unrealized hopes for CCSVI challenged but did not undermine the resilience of patient communities. The narrative that unfolded highlights the importance of drawing a socially-minded space for public participation in science.
topic Health services research
Public engagement
Multiple sclerosis
Chronic cerebrospinal venous insufficiency
Ethics
url http://link.springer.com/article/10.1186/s12913-018-3130-x
work_keys_str_mv AT shellybenjaminy resiliencetrustandcivicengagementinthepostccsviera
AT andrewschepmyer resiliencetrustandcivicengagementinthepostccsviera
AT judyilles resiliencetrustandcivicengagementinthepostccsviera
AT anthonytraboulsee resiliencetrustandcivicengagementinthepostccsviera
_version_ 1725841003586256896